Filing Details
Lexaria Bioscience Corp. (NASDAQ:LEXX) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
8k filedNASDAQ:LEXX
Lexaria Bioscience Corp. (LEXX) Reports Material Event to SEC
Lexaria Bioscience Corp. (NASDAQ:LEXX) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
At publication ·
What changed
Lexaria Bioscience Corp. (NASDAQ:LEXX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Lexaria Bioscience Corp. (NASDAQ: LEXX) filed a Form 8-K with the SEC on August 17, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $10.32 with a market capitalization of $22.4 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Lexaria Bioscience Corp.'s stock currently trades at $10.32 with a market capitalization of $22.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Lexaria Bioscience Corp.'s stock.
All SEC filings for Lexaria Bioscience Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LEXX Stock Page
Frequently Asked Questions
Where can I read LEXX's SEC filings?
Browse all filings on our LEXX SEC filings page.
What types of SEC filings does Lexaria Bioscience Corp. file?
Public companies like Lexaria Bioscience Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.